Literature DB >> 8824720

Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.

D E Schofield1, J B Beckwith, J Sklar.   

Abstract

Rhabdoid tumors of the kidney are highly malignant neoplasms that occur primarily within the first 3 years of life. Although they are regarded as distinct from Wilms' tumors, their pathogenesis remains unclear. Whereas most cytogenetic studies of these tumors have revealed normal karyotypes, a few reports have indicated abnormalities at chromosome regions 22q and 11p15.5. We analyzed 30 primary renal rhabdoid tumors for loss of heterozygosity (LOH) at both regions and found that 24 of 30 tumors (80%) had LOH at chromosome arm 22q and that 5 of 30 (17%) had LOH at chromosome band 11p15.5. All of the five tumors with LOH at chromosome arm 11p also had LOH at chromosome arm 22q. The data suggest that there is a gene in chromosome 22, probably a tumor suppressor, inactivation of which may be involved in the genesis of renal rhabdoid tumors. A second gene in chromosome segment 11p15.5, in the region of the putative WT2 gene, may also be involved, in at least a subset of rhabdoid tumors. In addition, five tumors were characterized by microsatellite instability at three or more of 21 loci examined, suggesting a possible role for a replicative error in tumorigenesis or progression in some cases of renal rhabdoid tumors. Genes Chromosom Cancer 15:10-17 (1996).

Entities:  

Mesh:

Year:  1996        PMID: 8824720     DOI: 10.1002/(SICI)1098-2264(199601)15:1<10::AID-GCC2>3.0.CO;2-7

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

1.  Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy.

Authors:  Peter H O'Donnell; Ana Jensen; Edwin M Posadas; Julia A Bridge; Anjana V Yeldandi; Ximing J Yang; Walter M Stadler; Hikmat Al-Ahmadie
Journal:  Nat Rev Urol       Date:  2010-02       Impact factor: 14.432

2.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Edward B Stelow; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2017-02-28

3.  Renal cell carcinoma with rhabdoid and sarcomatoid features presented as a metastatic thigh mass with an unusual immunohistochemical profile.

Authors:  Asmaa Gaber Abdou; Mona Kandil; Soliman Elshakhs; Marwa Serag El-Dien; Rania Abdallah
Journal:  Rare Tumors       Date:  2014-03-18

4.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

5.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Authors:  N Sévenet; E Sheridan; D Amram; P Schneider; R Handgretinger; O Delattre
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

Review 6.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Malignant rhabdoid tumour of the perineum in an adult-a rare presentation.

Authors:  Rajdeep Singh; Baljeet Kumar Basra; Nita Khurana; Anil Kumar Sarda
Journal:  Indian J Surg       Date:  2012-07-04       Impact factor: 0.656

Review 8.  Malignant rhabdoid tumour of the oesophagus: a case report.

Authors:  W C Ng; H T Leong; K F Ma; W L Yip; W M Suen
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

9.  SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.

Authors:  Justin A Bishop; Cristina R Antonescu; William H Westra
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

Review 10.  Case-based review: atypical teratoid/rhabdoid tumor.

Authors:  Cody L Nesvick; Amulya A Nageswara Rao; Aditya Raghunathan; Jaclyn A Biegel; David J Daniels
Journal:  Neurooncol Pract       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.